Elekta AB (publ) (STO:EKTA.B)
Sweden · Delayed Price · Currency is SEK 52.40
+0.35 (0.67%)
At close: Jun 12, 2026
Elekta AB Market Cap
Elekta AB has a market cap or net worth of 20.02 billion as of June 12, 2026. Its market cap has increased by 4.59% in one year.
Market Cap
20.02B
Enterprise Value
24.21B
Revenue
16.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
52.40
Market Cap Chart
Since September 4, 1997, Elekta AB's market cap has increased from 1.51B to 20.02B, an increase of 1,229.09%. That is a compound annual growth rate of 9.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 20.02B | -7.67% |
| Dec 30, 2025 | 21.68B | -7.20% |
| Dec 30, 2024 | 23.36B | -25.72% |
| Dec 29, 2023 | 31.45B | 31.08% |
| Dec 30, 2022 | 23.99B | -45.18% |
| Dec 30, 2021 | 43.77B | 3.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 58.19B |
| Getinge AB | 53.45B |
| Nolato AB | 13.19B |
| Vitrolife AB | 12.97B |
| Xvivo Perfusion AB | 8.60B |
| MedCap AB | 7.47B |
| CellaVision AB | 3.30B |
| Devyser Diagnostics AB | 1.51B |